In a prior trial STEP 4, patients were observed off semaglutide after a 20-week treatment period but continued with lifestyle intervention support
Weight regain is possible if you don't maintain healthy lifestyle changes
Analysis of safety and pharmacodynamics of SANA in human volunteers Based on all the accumulated preclinical evidence supporting that SANA might be a suitable first-in-class drug for treatment of obesity and comorbidities, we performed a randomized, double-blind, placebo-controlled phase 1A/B clinical trial in healthy lean volunteers and in volunteers with obesity
A.SmertinaiteL.FangF.IngreC.TaubeF
How Fast Do B12 Levels Rise After Starting Treatment
But the findings in weight were also very robust. She added: And those findings in weight were a trigger to say, OK, we will have our Type 2 diabetes indication and program but we may have a drug that may work on chronic weight management. Astounded So, in 2019, the company began setting up a series of clinical trials that would test primarily for obesity